Aclarion, Inc. (NASDAQ:ACONW) Short Interest Down 65.8% in April

Aclarion, Inc. (NASDAQ:ACONW) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 100 shares, a decline of 65.8% from the April 15th total of 292 shares. Based on an average daily volume of 7,518 shares, the short-interest ratio is presently 0.0 days.

Aclarion Price Performance

Shares of Aclarion stock remained flat at $0.03 during mid-day trading on Friday. 1,800 shares of the stock traded hands, compared to its average volume of 13,002. The firm’s 50-day simple moving average is $0.04 and its 200-day simple moving average is $0.04. Aclarion has a twelve month low of $0.02 and a twelve month high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.